The Regier Lab is an innovative program of research focused on the sustainability, value and social impacts of precision medicine. Our research initiatives identify community-defined risks and benefits of precision medicine, its cost-effectiveness, and what policy changes can support the responsible and equitable application of multi-omics. Our research studies estimate preference-based utility and acceptability of multi-omic technologies, as well as include value for money assessments.
The PACER lab leads the health economics activities of this multi-year research project in collaboration with researchers from the Genome Sciences Centre and the Centre for Lymphoid Cancer.
The GeneSolve study, recently funded by Genome British Columbia, examines the value of genomic sequencing for diagnosing childhood rare diseases.
BC Cancer’s Personalized OncoGenomics (POG) Program is a world-leading initiative applying whole-genome and transcriptome analysis (WGTA) to inform real-time treatment decisions for patients with advanced, hard-to-treat cancers. Using a mixed methods approach, Dr.
The CIHR-funded Catalyst project applies a mixed methods approach to enhancing shared decision-making in context to the return of genetic test results for hereditary cancer syndromes.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.
